EC Number |
Inhibitors |
Structure |
---|
2.7.10.2 | (2-[2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl]-1,3-thiazol-4-yl)methanol |
- |
|
2.7.10.2 | (2-[2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl]-1,3-thiazol-5-yl)methanol |
- |
|
2.7.10.2 | (2E)-3-(6-bromopyridin-2-yl)-2-cyano-N-[(1S)-1-phenylethyl]prop-2-enamide |
WP1066 |
|
2.7.10.2 | (2E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide |
LS104 |
|
2.7.10.2 | (2E,4E)-N-benzyl-2-cyano-5-(3,4-dihydroxyphenyl)penta-2,4-dienamide |
AG490, potent JAK2 inhibitor |
|
2.7.10.2 | (4E,6Z,8S,9S,10E,12S,13R,14S,16S,17R)-8,13,14,17-tetramethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate |
indirect pharmacological inhibitor |
|
2.7.10.2 | 1-(4-((5-methyl-2-((4-morpholinophenyl)amino)pyrimidin-4-yl) amino)piperidin-1-yl)ethan-1-one |
100 nM, 70.5% inhibition. 28°C, pH not specified in the publication |
|
2.7.10.2 | 1-(4-(5-methyl-2-((4-morpholinophenyl)amino)pyrimidin-4-yl) piperazin-1-yl)ethan-1-one |
100 nM, 66.2% inhibition. 28°C, pH not specified in the publication |
|
2.7.10.2 | 1-(4-(5-methyl-2-((4-morpholinophenyl)amino)pyrimidin-4-yl) piperazin-1-yl)pentane-1,4-dione |
100 nM, 56.4% inhibition. 28°C, pH not specified in the publication |
|
2.7.10.2 | 1-(4-(5-methyl-2-((4-morpholinophenyl)amino)pyrimidin-4-yl) piperazin-1-yl)propan-1-one |
100 nM, 73.4% inhibition. 28°C, pH not specified in the publication |
|